首页> Cardiology in review> Safety and Outcomes with Direct Oral Anticoagulants Versus Vitamin-K Antagonists in Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review, Meta-Analysis, and Meta-Regression.

Safety and Outcomes with Direct Oral Anticoagulants Versus Vitamin-K Antagonists in Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review, Meta-Analysis, and Meta-Regression.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hritvik,Jain

第一单位： From the Department of Internal Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India.

作者： Hritvik,Jain ^[1] ; Ramez M,Odat ^[2] ; Mushood,Ahmed ^[3] ; Jyoti,Jain ^[1] ; Aman,Goyal ^[4] ; Muhammad,Idrees ^[5] ; Siddhant,Passey ^[6] ; Jagriti,Jha ^[7] ; Janhvi,Shah ^[8] ; Shrey,Gole ^[9]

作者单位： From the Department of Internal Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur, India. ^[1] Department of Internal Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan. ^[2] Department of Internal Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan. ^[3] Department of Internal Medicine, Seth GS Medical College and KEM Hospital, Mumbai, India. ^[4] Department of Internal Medicine, Lahore General Hospital, Lahore, Pakistan. ^[5] Department of Internal Medicine, University of Connecticut Health Center, CT. ^[6] Department of Pediatrics, University of Connecticut Health Center, CT. ^[7] Department of Internal Medicine, St Luke's Hospital, Chesterfield, MO. ^[8] Department of Immunology and Rheumatology, Stanford University, CA. ^[9]

DOI 10.1097/CRD.0000000000000735

PMID 38833432

发布时间 2024-06-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交